LEUKEMIA, MYELOID
Clinical trials for LEUKEMIA, MYELOID explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CML drug combo aims for deeper remission without lifelong side effects
Disease control Recruiting nowThis study tests a new drug called asciminib as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug doesn't work well enough after up to 3 years, patients can also get a low dose of another standard drug. The goal is to see if this appr…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE2 • Sponsor: Augusta University • Aim: Disease control
Last updated May 26, 2026 07:11 UTC
-
Immune cell boost plus targeted drug shows promise in early AML trial
Disease control Recruiting nowThis early-phase study tests the safety of giving special immune cells (CIML NK cells) along with a standard drug (venetoclax) to adults with acute myeloid leukemia (AML). The treatment aims to help the body's natural killer cells fight leukemia more effectively. About 10 partici…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
Immune cell boost after transplant aims to stop cancer return
Disease control Recruiting nowThis early-phase study tests whether specially trained immune cells (CIML NK cells) given after a stem cell transplant can safely prevent leukemia or related blood cancers from coming back. About 15 adults with high-risk acute myeloid leukemia, myelodysplastic syndrome, or relate…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
New pill for tough leukemia cases enters human testing
Disease control Recruiting nowThis early-stage study tests a new daily pill, BH-30236, in adults whose acute myeloid leukemia or high-risk myelodysplastic syndrome has returned or stopped responding to other treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink ca…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: BlossomHill Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
New hope for Hard-to-Treat leukemia: drug combo trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called ziftomenib combined with standard treatments for people with a type of acute myeloid leukemia (AML) that has come back or not responded to therapy. The main goal is to check safety and find the best dose. About 171 adults with specif…
Matched conditions: LEUKEMIA, MYELOID
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC